Humacyte, Inc. HUMA

0.56 (0.01) (1.75%) as of 25 Sep
Market cap
$166.7M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Net Income
(96.73) (97.59) (40.83) (36.97)

+8 more TTM periods

Depreciation & Amortization
7.81 7.59 7.35 7.37
Non Cash Items (Other)
4.19 3.60 (48.16) (58.31)
Accounts Receivable Change
0.06 0.05 (0.26) (0.90)
Change in inventories
(6.55) (11.76) (21.83) —
Accounts Payable Change
(2.45) (0.04) 0.97 2.70
Change in other assets and liabilities
(3.52) (3.38) (2.28) (1.11)
Operating Cash Flow
(97.19) (101.54) (105.04) (105.49)
Capital expenditures
(0.37) (0.83) (0.88) (0.91)
Investing cash flow
(0.37) (0.83) (0.88) (0.91)
Repayment/Issuance of Debt (Net)
37.54 — 37.03 (2.83)
Equity Repurchase (Common, Net)
139.81 89.34 113.44 108.54
Other financial activities
— — (88.98) (50.38)
Financing cash flow
89.43 38.07 61.49 55.32
Change in Cash
(8.13) (64.31) (44.44) (51.08)
Beginning Cash
50.85 50.85 95.29 95.29
Ending Cash
42.72 (13.46) 50.85 44.21
Stock Based Compensation
10.71 10.44 9.75 8.98
Dividends Paid (Common)
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(12.46) (15.14) (23.39) (17.58)
Issuance/Purchase of Shares
139.81 89.34 113.44 108.54

Fold the line items

In millions of $ except per-share values · columns are period end dates